NeoVolta Announces Vision for Rapid Growth in CEO Ardes Johnson’s letter to shareholders
SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV), a leading innovator in advanced energy storage systems, […]
Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
Liquidia to feature two live posters sessions and five encore presentations covering its investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal [...]
VIVOPOWER’S TEMBO SECURES 200 TUSKERS WORTH US$10M
Tembo has secured a minimum of 200 Tuskers for the Australia and NZ markets Australian sales of pick up trucks […]
VCI Global Partners With Treasure Global Inc. to Accelerate E-Commerce and Fintech Growth in Southeast Asia
KUALA LUMPUR, Malaysia, June 18, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), […]
Reliance Global Group Provides Update on Pending Spetner Acquisition
Transformational acquisition expected to close in the second half of 2024 Projected to double Company’s annualized revenue to approximately $28 […]
AgriFORCE Appoints Jolie Kahn as Chief Executive Officer
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual […]
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field […]
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative […]
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on […]
Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology
New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness Findings consistent with another study recently published in […]
